E-LIB Suche - Ergebnisse für: Gan'shina, E.A

1

Influence of size effects and granule distribution by size ..:

A. N. Yurasov ; M. M. Yashin ; I. V. Gladyshev...
https://www.rtj-mirea.ru/jour/article/view/327. , 2021

Link: https://doi.org/10.32362..

2

Verification of Gamification Tools as an Acute Trend of Mot..:

E. U. Ganshina ; I. L. Smirnova ; S. P. Ivanova
https://vest.rea.ru/jour/article/view/1386. , 2022

Link: https://doi.org/10.21686..

3

Interrelation between the Choice of Investment Trend and Su..:

E. U. Ganshina ; I. L. Smirnova ; S P. Ivanova
https://vest.rea.ru/jour/article/view/1091. , 2021

Link: https://doi.org/10.21686..

4

Factors of Digitalization in Providing Sustainable Organiza..:

E. U. Ganshina ; I. L. Smirnova ; S. P. Ivanova
https://vest.rea.ru/jour/article/view/839. , 2020

Link: https://doi.org/10.21686..

5

Optimal duration of adjuvant trastuzumab therapy in patient..:

Zhukova L.G ; Ganshina I.P ; Khatkova E.I..
https://doi.org/10.26442/1815-1434_2018.2.24-28. , 2020

Link: https://openrepository.r..

6

Russian multicenter experience of using talazoparib in the ..:

T. Semiglazova Yu ; E. Lubennikova V ; L. Bolotina V...
https://www.med-sovet.pro/jour/article/view/5937/5420. , 2020

Link: https://www.med-sovet.pr..

7

ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LY..:

A. Chertkova I ; E. Slavina G ; T. Zabotina N...
https://www.siboncoj.ru/jour/article/view/1641/809. , 2020

Link: https://www.siboncoj.ru/..

8

Olaparib in the metastatic HER2-negative breast cancer sett..:

L. Zhukova G ; E. Khatkova I ; I. Ganshina P...
https://www.med-sovet.pro/jour/article/view/5930/5414. , 2020

Link: https://www.med-sovet.pr..

9

Ribociclib for the treatment of hormone-positive HER2-negat..:

I. Ganshina P ; D. Filonenko A ; O. Gordeeva O...
https://www.med-sovet.pro/jour/article/view/3055/2979. , 2019

Link: https://www.med-sovet.pr..

10

EXPERIENCE WITH SUBCUTANEOUS TRASTUZUMAB USED IN RUSSIAN FE..:

E. Lubennikova V ; I. Ganshina P ; A. Lud N...
https://www.med-sovet.pro/jour/article/view/2165/2148. , 2017

Link: https://www.med-sovet.pr..

11

Experience of using talazoparib in the aggressive course of..:

A. S. Tsareva ; E. V. Lubennikova ; A. A. Rumyantsev...
https://www.med-sovet.pro/jour/article/view/7700/6832. , 2023

Link: https://www.med-sovet.pr..

12

Alpelisib therapy: from theory to practice:

E. V. Lubennikova ; T. A. Titova ; I. P. Ganshina
https://www.med-sovet.pro/jour/article/view/6917. , 2022

Link: https://doi.org/10.21518..

13

Alpelisib therapy: from theory to practice ; Терапия алпели..:

E. V. Lubennikova ; T. A. Titova ; I. P. Ganshina...
https://www.med-sovet.pro/jour/article/view/6917/6215. , 2022

Link: https://www.med-sovet.pr..

14

Analysis of the efficacy and safety of eribulin therapy in ..:

Irina V. Kolyadina ; Natalia R. Abidova ; Arshak A. Akopyan...
https://modernonco.orscience.ru/1815-1434/article/viewFile/70308/51242. , 2021

Link: https://doi.org/10.26442..

15

The consensus on the prevention and correction of rash in p..:

Irena L. Shlivko ; Oxana E. Garanina ; Elena V. Artamonova...
https://modernonco.orscience.ru/1815-1434/article/viewFile/100019/73503. , 2021

Link: https://doi.org/10.26442..